CD44 and breast carcinoma: Single-cell RNA-Seq analysis conducted with breast cancer CSCs showed a population with hybrid EMT and CSC markers CD44, ABCG2, and ALDH1A1/3, which might mark the MICs (Akrap et al., 2016).